Technical Analysis for RCE - Recce Ltd
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Flat | Up |
See historical RCE trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 3.77% | |
Narrow Range Bar | Range Contraction | 3.77% | |
Narrow Range Bar | Range Contraction | 3.77% | |
NR7 | Range Contraction | 3.77% | |
20 DMA Support | Bullish | 3.77% | |
20 DMA Support | Bullish | 1.85% | |
50 DMA Resistance | Bearish | 3.77% | |
Bearish Engulfing | Bearish | 3.77% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 3.77% | |
Crossed Above 20 DMA | Bullish | 0.00% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
Recce Limited is an Australia-based research-based pharmaceutical company. The Company is principally engaged in research and development of antibiotic drugs and anticancer drugs. The Company's antibiotics kill both susceptible bacteria and drug resistant super bugs throughout the world health danger arising from resistance to present-day antibiotics. The Company offers antibiotic drugs to treat the diseases caused by Sepsis, Helicobacter Pylori (H.Pylori), Escherichia coli (E.coli), Gonorrhea and Tuberculosis (TB). The Company offers anticancer drugs to treat various cancers, such as leukemia, prostate, lung, stomach, intestine, kidney and melanoma. The Company also offers polymer-antibiotics targeted for human use. The Company's Recce antibiotic kills all types of bacteria, including superbugs. Its subsidiaries include Recce (USA) LLP and Recce (UK) Limited.
Medicine Health Cancer Chemotherapy Diseases Pharmaceuticals Policy Cancers Bacteriology Antibiotics Bacteria Leukemia Melanoma Veterinary Medicine Antibiotic
Medicine Health Cancer Chemotherapy Diseases Pharmaceuticals Policy Cancers Bacteriology Antibiotics Bacteria Leukemia Melanoma Veterinary Medicine Antibiotic
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Date | Title |
---|
Indicator | Value |
---|---|
52 Week High | 0.435 |
52 Week Low | 0.13 |
Average Volume | 428,915 |
200-Day Moving Average | 0.229 |
50-Day Moving Average | 0.274 |
20-Day Moving Average | 0.262 |
10-Day Moving Average | 0.266 |
Average True Range | 0.016 |
ADX | 16.05 |
+DI | 24.465 |
-DI | 19.395 |
Chandelier Exit (Long, 3 ATRs ) | 0.249 |
Chandelier Exit (Short, 3 ATRs ) | 0.287 |
Upper Bollinger Band | 0.279 |
Lower Bollinger Band | 0.245 |
Percent B (%b) | 0.59 |
BandWidth | 12.901 |
MACD Line | -0.001 |
MACD Signal Line | -0.002 |
MACD Histogram | 0.0009 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.273 | ||||
Resistance 3 (R3) | 0.272 | 0.268 | 0.271 | ||
Resistance 2 (R2) | 0.268 | 0.266 | 0.269 | 0.271 | |
Resistance 1 (R1) | 0.267 | 0.265 | 0.268 | 0.268 | 0.270 |
Pivot Point | 0.263 | 0.263 | 0.264 | 0.264 | 0.263 |
Support 1 (S1) | 0.262 | 0.261 | 0.263 | 0.263 | 0.260 |
Support 2 (S2) | 0.258 | 0.260 | 0.259 | 0.259 | |
Support 3 (S3) | 0.257 | 0.258 | 0.259 | ||
Support 4 (S4) | 0.258 |